Joeri Kint
Boxmeer, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern.
Journal: Vaccines
Published: March 05, 2022
High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens.
Journal: Microbiology spectrum
Published: February 16, 2022
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame.
Journal: NPJ vaccines
Published: September 02, 2021
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
Journal: Biochemistry
Published: July 02, 2021
Site-specific steric control of SARS-CoV-2 spike glycosylation.
Journal: bioRxiv : the preprint server for biology
Published: March 24, 2021
Infectious Bronchitis Coronavirus Limits Interferon Production by Inducing a Host Shutoff That Requires Accessory Protein 5b.
Journal: Journal of virology
Published: April 03, 2016
Infectious Bronchitis Coronavirus Inhibits STAT1 Signaling and Requires Accessory Proteins for Resistance to Type I Interferon Activity.
Journal: Journal of virology
Published: April 22, 2015
Quantification of infectious bronchitis coronavirus by titration in vitro and in ovo.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 28, 2015
Quantification of interferon signaling in avian cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 28, 2015
Activation of the chicken type I interferon response by infectious bronchitis coronavirus.
Journal: Journal of virology
Published: November 08, 2014
Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus.
Journal: PLoS pathogens
Published: October 10, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026